Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. It operates through two segments, the Animal Health Business Unit, and the Pharmacy Business Unit. The company engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics. It provides pharmaceuticals, which includes sedaject, ataject, and thyro-tabs canine drugs; and wound care products, including medical tubes, viscose net dressings, elastic bandages, and silicone perforated tapes, as well as medical pet shirt protective wear that comprise pet shirt, pets boot, head cover, and leg sleeves. The company also offers disposables comprising syringes, needles, and IV catheters; and nutraceuticals, which includes Composure Pro, Vertiflex, hide and treat, L-Lysine Pro, Renal Essentials Pro, and Hepaticlear Pro, as well as Entero Aid +Gi and Fibre Boost +Gi health products. Grey Wolf Animal Health Corp. is headquartered in Toronto, Canada.
Metrics to compare | WOLF | Sector Sector - Average of metrics from a broad group of related Consumer Cyclicals sector companies | Relationship RelationshipWOLFPeersSector | |
---|---|---|---|---|
P/E Ratio | 36.7x | −2.9x | −0.6x | |
PEG Ratio | −0.40 | 0.01 | 0.00 | |
Price / Book | 1.0x | 0.6x | 2.6x | |
Price / LTM Sales | 1.0x | 1.7x | 3.3x | |
Upside (Analyst Target) | - | 314.6% | 44.5% | |
Fair Value Upside | Unlock | 16.1% | 6.0% | Unlock |